Cargando…

Estimation of Utility Weights for Prostate-related Health States in Korea

OBJECTIVES: Very limited previous research has investigated the utility weights of prostate-related diseases in the general population in Korea. The purpose of this study was to calculate the utility of prostate-related health states in the Korean general public using the standard gamble (SG) method...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seon-Ha, Ock, Minsu, Jo, Min-Woo, Park, Sungchan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Preventive Medicine 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201095/
https://www.ncbi.nlm.nih.gov/pubmed/35677998
http://dx.doi.org/10.3961/jpmph.21.426
_version_ 1784728218185498624
author Kim, Seon-Ha
Ock, Minsu
Jo, Min-Woo
Park, Sungchan
author_facet Kim, Seon-Ha
Ock, Minsu
Jo, Min-Woo
Park, Sungchan
author_sort Kim, Seon-Ha
collection PubMed
description OBJECTIVES: Very limited previous research has investigated the utility weights of prostate-related diseases in the general population in Korea. The purpose of this study was to calculate the utility of prostate-related health states in the Korean general public using the standard gamble (SG) method. METHODS: Seven health states for hypothetical prostate cancers, 1 for benign prostate hyperplasia, and 1 for erectile dysfunction were developed based on patient education material and previous publications. In total, 460 responses from the Korean general population were used to analyze the utility of prostate-related health states. Computer-assisted personal interviews were conducted, and utility values were measured using a visual analogue scale (VAS) and SG. Mean utility values were calculated for each prostate-related health state. RESULTS: The mean utility values of prostate cancer derived from SG ranged from 0.281 (metastatic castration-refractory prostate cancer) to 0.779 (localized prostate cancer requiring prostatectomy). The utility value of benign prostate hyperplasia was 0.871, and that of erectile dysfunction was 0.812. The utility values obtained using the SG method in all conditions were higher than the values obtained by VAS. There were no significant demographic variables affecting utility values in multivariate analysis. CONCLUSIONS: Our findings might be useful for economic evaluation and utility calculation of screening and interventions for prostate-related conditions in the general population.
format Online
Article
Text
id pubmed-9201095
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Korean Society for Preventive Medicine
record_format MEDLINE/PubMed
spelling pubmed-92010952022-07-06 Estimation of Utility Weights for Prostate-related Health States in Korea Kim, Seon-Ha Ock, Minsu Jo, Min-Woo Park, Sungchan J Prev Med Public Health Original Article OBJECTIVES: Very limited previous research has investigated the utility weights of prostate-related diseases in the general population in Korea. The purpose of this study was to calculate the utility of prostate-related health states in the Korean general public using the standard gamble (SG) method. METHODS: Seven health states for hypothetical prostate cancers, 1 for benign prostate hyperplasia, and 1 for erectile dysfunction were developed based on patient education material and previous publications. In total, 460 responses from the Korean general population were used to analyze the utility of prostate-related health states. Computer-assisted personal interviews were conducted, and utility values were measured using a visual analogue scale (VAS) and SG. Mean utility values were calculated for each prostate-related health state. RESULTS: The mean utility values of prostate cancer derived from SG ranged from 0.281 (metastatic castration-refractory prostate cancer) to 0.779 (localized prostate cancer requiring prostatectomy). The utility value of benign prostate hyperplasia was 0.871, and that of erectile dysfunction was 0.812. The utility values obtained using the SG method in all conditions were higher than the values obtained by VAS. There were no significant demographic variables affecting utility values in multivariate analysis. CONCLUSIONS: Our findings might be useful for economic evaluation and utility calculation of screening and interventions for prostate-related conditions in the general population. Korean Society for Preventive Medicine 2022-05 2022-05-04 /pmc/articles/PMC9201095/ /pubmed/35677998 http://dx.doi.org/10.3961/jpmph.21.426 Text en Copyright © 2022 The Korean Society for Preventive Medicine https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kim, Seon-Ha
Ock, Minsu
Jo, Min-Woo
Park, Sungchan
Estimation of Utility Weights for Prostate-related Health States in Korea
title Estimation of Utility Weights for Prostate-related Health States in Korea
title_full Estimation of Utility Weights for Prostate-related Health States in Korea
title_fullStr Estimation of Utility Weights for Prostate-related Health States in Korea
title_full_unstemmed Estimation of Utility Weights for Prostate-related Health States in Korea
title_short Estimation of Utility Weights for Prostate-related Health States in Korea
title_sort estimation of utility weights for prostate-related health states in korea
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201095/
https://www.ncbi.nlm.nih.gov/pubmed/35677998
http://dx.doi.org/10.3961/jpmph.21.426
work_keys_str_mv AT kimseonha estimationofutilityweightsforprostaterelatedhealthstatesinkorea
AT ockminsu estimationofutilityweightsforprostaterelatedhealthstatesinkorea
AT jominwoo estimationofutilityweightsforprostaterelatedhealthstatesinkorea
AT parksungchan estimationofutilityweightsforprostaterelatedhealthstatesinkorea